Search

Your search keyword '"Dehais, Caroline"' showing total 253 results

Search Constraints

Start Over You searched for: Author "Dehais, Caroline" Remove constraint Author: "Dehais, Caroline"
253 results on '"Dehais, Caroline"'

Search Results

2. An AI-powered blood test to detect cancer using nanoDSF

5. Neuro-Psychological Outcome of ICU-Admitted COVID-19 Patients Presenting With CNS Complications

7. Mechanisms and therapeutic implications of hypermutation in gliomas

8. A threshold for mitotic activity and post‐surgical residual volume defines distinct prognostic groups for astrocytoma IDH‐mutant

9. Mismatch Repair Deficiency and Lynch Syndrome Among Adult Patients With Glioma

10. Supplementary Tables from Safety and Feasibility of Repeated and Transient Blood–Brain Barrier Disruption by Pulsed Ultrasound in Patients with Recurrent Glioblastoma

12. T2‐Fluid‐attenuated inversion recovery (FLAIR) pseudoprogression in patients with anaplastic oligodendrogliomas treated with procarbazine, lomustine and vincristine (PCV) chemotherapy alone.

13. In Vivo 2-Hydroxyglutarate Monitoring With Edited MR Spectroscopy for the Follow-up of IDH-Mutant Diffuse Gliomas

14. Characteristics, Patterns of Care and Predictive Geriatric Factors in Elderly Patients Treated for High-Grade IDH-Mutant Gliomas: A French POLA Network Study

15. PATH-16. THRESHOLDS OF MITOTIC ACTIVITY AND POST-SURGERY RESIDUAL VOLUME ARE INDEPENDENT PROGNOSTIC FACTORS IN ASTROCYTOMA IDH-MUTANT

18. Incidence and characteristics of pseudoprogression in IDH-mutant high-grade gliomas: A POLA network study

20. A Multigene Signature Associated with Progression-Free Survival after Treatment for IDH Mutant and 1p/19q Codeleted Oligodendrogliomas.

22. Prognostic impact of the 2016 WHO classification of diffuse gliomas in the French POLA cohort

23. Tumor cells with neuronal intermediate progenitor features define a subgroup of 1p/19q co‐deleted anaplastic gliomas

24. Incidence and characteristics of pseudoprogression in IDH-mutant high-grade gliomas: A POLA network study.

27. The wide spectrum of COVID-19 neuropsychiatric complications within a multidisciplinary centre

29. NCOG-09. PREDICTIVE GERIATRIC FACTORS IN ELDERLY PATIENTS TREATED FOR IDH-MUTANT HIGH-GRADE GLIOMAS: A FRENCH POLA NETWORK STUDY

30. Sustained Tumor Control With MAPK Inhibition in BRAF V600–Mutant Adult Glial and Glioneuronal Tumors

31. Prognostic Relevance of Histomolecular Classification of Diffuse Adult High-Grade Gliomas with Necrosis

33. Hybrid [18F]-F-DOPA PET/MRI Interpretation Criteria and Scores for Glioma Follow-up After Radiotherapy.

35. Radiotherapy‐PCV versus radiotherapy‐temozolomide for IDH ‐mutant anaplastic astrocytoma: a retrospective multicentre analysis of the French POLA cohort

37. Characteristics of Anaplastic Oligodendrogliomas Short-Term Survivors: A POLA Network Study.

41. An AI-Powered Blood Test to Detect Cancer Using NanoDSF

42. Radiotherapy Plus Procarbazine, Lomustine, and Vincristine Versus Radiotherapy Plus Temozolomide for IDH-Mutant Anaplastic Astrocytoma: A Retrospective Multicenter Analysis of the French POLA Cohort

43. Severe COVID-19-related encephalitis can respond to immunotherapy

44. The cerebral network of COVID-19-related encephalopathy: a longitudinal voxel-based 18F-FDG-PET study

47. Abstract 5705: Mechanisms and therapeutic implications of hypermutation in gliomas

48. An AI-powered blood test to detect cancer using nanoDSF

49. 5-Azacitidine in patients with IDH1/2-mutant recurrent glioma

50. Germline mutations in the new E1’ cryptic exon of the VHL gene in patients with tumours of von Hippel-Lindau disease spectrum or with paraganglioma

Catalog

Books, media, physical & digital resources